| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institute of Chemistry 1 (Nuclear Chemistry), Nuclear Research Centre Jülich GmbH, Jülich, FRG
Correspondence: For reprints contact: H. H. Coenen, PhD, Institut für Chemie 1 (Nuklearchemie), Kernforschungsanlage Jülich GmbH, D-5170 Jülich.
ABSTRACT
L-[2-18F]fluorotyrosine (2-18FTyr) was evaluated as a tracer of cerebral protein synthesis for positron emission tomography (PET). Its metabolism in murine cerebrum was studied. The uptake in brain reaches a value of 
2% of the injected dose per gram tissue after 60 min. The incorporation of the tracer into tissue proteins was proven by discontinuous SDS gel electrophoresis. The protein bound fraction of tissue activity increased to 84% and 89% after 60 and 120 min p.i., respectively. High performance liquid chromatography analysis showed a concomitant decrease of free 2-18FTyr in tissue with time. The sum of free 2-18FTyr, tRNA-and protein-bound 2-18FTyr in cerebral tissue gave an almost quantitative activity balance of 96 ± 4% at all times examined. A significant formation of fluorodopa or fluorodopamine must therefore be excluded. This shows that L-[2-18F]fluorotyrosine is a promising tracer for quantitation of protein synthesis rates with PET based on a three-compartment model.
This article has been cited by other articles:
|
|
 |
|
  C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Haase, R. Bergmann, F. Fuechtner, A. Hoepping, and J. Pietzsch L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-L-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo J. Nucl. Med., December 1, 2007; 48(12): 2063 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsukada, K. Sato, D. Fukumoto, S. Nishiyama, N. Harada, and T. Kakiuchi Evaluation of D-Isomers of O-11C-Methyl Tyrosine and O-18F-Fluoromethyl Tyrosine as Tumor-Imaging Agents in Tumor-Bearing Mice: Comparison with L- and D-11C-Methionine J. Nucl. Med., April 1, 2006; 47(4): 679 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bergmann, J. Pietzsch, F. Fuechtner, B. Pawelke, B. Beuthien-Baumann, B. Johannsen, and J. Kotzerke 3-O-Methyl-6-18F-Fluoro-L-Dopa, a New Tumor Imaging Agent: Investigation of Transport Mechanism In Vitro J. Nucl. Med., December 1, 2004; 45(12): 2116 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-J. Langen and S. Broer Molecular Transport Mechanisms of Radiolabeled Amino Acids for PET and SPECT J. Nucl. Med., September 1, 2004; 45(9): 1435 - 1436. [Full Text] [PDF]
|
|
|
|
|
|
R. Hustinx, C. Lemaire, G. Jerusalem, P. Moreau, D. Cataldo, B. Duysinx, J. Aerts, M.-F. Fassotte, J. Foidart, and A. Luxen Whole-Body Tumor Imaging Using PET and 2-18F-Fluoro-L-Tyrosine: Preliminary Evaluation and Comparison with 18F-FDG J. Nucl. Med., April 1, 2003; 44(4): 533 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lahoutte, V. Caveliers, P. R. Franken, A. Bossuyt, J. Mertens, and H. Everaert Increased Tumor Uptake of 3-123I-Iodo-L-{alpha}-Methyltyrosine After Preloading with Amino Acids: An In Vivo Animal Imaging Study J. Nucl. Med., September 1, 2002; 43(9): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Inoue, K. Koyama, N. Oriuchi, S. Alyafei, Z. Yuan, H. Suzuki, K. Takeuchi, Y. Tomaru, K. Tomiyoshi, J. Aoki, et al. Detection of Malignant Tumors: Whole-Body PET with Fluorine 18 {{alpha}}-Methyl Tyrosine versus FDG—Preliminary Study Radiology, July 1, 2001; 220(1): 54 - 62. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
